Edwards Lifesciences Corp Quarterly Unrecognized Tax Benefits in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Edwards Lifesciences Corp quarterly Unrecognized Tax Benefits history and growth rate from Q4 2010 to Q3 2024.
  • Edwards Lifesciences Corp Unrecognized Tax Benefits for the quarter ending September 30, 2024 was $657M, a 20.9% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $657M +$114M +20.9% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $619M +$99.1M +19.1% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $609M +$112M +22.5% Mar 31, 2024 10-Q 2024-04-29
Q4 2023 $584M +$109M +22.8% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $543M +$125M +29.8% Sep 30, 2023 10-Q 2023-10-27
Q2 2023 $520M +$122M +30.5% Jun 30, 2023 10-Q 2023-07-28
Q1 2023 $497M +$117M +30.8% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 $475M +$117M +32.6% Dec 31, 2022 10-K 2024-02-12
Q3 2022 $418M +$77.5M +22.7% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $399M +$79.8M +25% Jun 30, 2022 10-Q 2022-07-29
Q1 2022 $380M +$79.4M +26.4% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $358M +$76.6M +27.2% Dec 31, 2021 10-K 2024-02-12
Q3 2021 $341M +$90.3M +36% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $319M +$95.5M +42.8% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $301M +$88.6M +41.8% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $282M +$78.7M +38.7% Dec 31, 2020 10-K 2024-02-12
Q3 2020 $251M +$64.3M +34.5% Sep 30, 2020 10-Q 2020-10-26
Q2 2020 $223M +$50.3M +29.1% Jun 30, 2020 10-Q 2020-07-27
Q1 2020 $212M +$8.8M +4.33% Mar 31, 2020 10-Q 2020-04-28
Q4 2019 $203M +$52.4M +34.8% Dec 31, 2019 10-K 2023-02-13
Q3 2019 $186M +$33.7M +22.1% Sep 30, 2019 10-Q 2019-10-25
Q2 2019 $173M +$23.3M +15.6% Jun 30, 2019 10-Q 2019-07-26
Q1 2019 $203M -$26.2M -11.4% Mar 31, 2019 10-K 2020-02-14
Q4 2018 $151M -$74.9M -33.2% Dec 31, 2018 10-K 2022-02-14
Q3 2018 $153M +$10.1M +7.09% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 $150M +$2.5M +1.7% Jun 30, 2018 10-Q 2018-07-27
Q1 2018 $229M +$84.7M +58.6% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $226M -$19.9M -8.11% Dec 31, 2017 10-K 2021-02-12
Q3 2017 $142M -$89M -38.5% Sep 30, 2017 10-Q 2017-10-27
Q2 2017 $147M -$78.2M -34.7% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 $145M -$77.4M -34.9% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $246M +$29.4M +13.6% Dec 31, 2016 10-K 2020-02-14
Q3 2016 $231M +$19M +8.95% Sep 30, 2016 10-Q 2016-10-28
Q2 2016 $225M +$23.7M +11.8% Jun 30, 2016 10-Q 2016-07-29
Q1 2016 $222M +$26.2M +13.4% Mar 31, 2016 10-Q 2016-04-29
Q4 2015 $216M +$23.8M +12.4% Dec 31, 2015 10-K 2019-02-15
Q3 2015 $212M +$31.8M +17.6% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 $202M +$29.6M +17.2% Jun 30, 2015 10-Q 2015-07-29
Q1 2015 $196M +$62.6M +47% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 $192M +$64.6M +50.6% Dec 31, 2014 10-K 2018-02-16
Q3 2014 $181M +$52.4M +40.9% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 $172M +$46.7M +37.3% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 $133M +$11.6M +9.54% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 $128M +$14.1M +12.4% Dec 31, 2013 10-K 2017-02-17
Q3 2013 $128M +$33.3M +35.1% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 $125M +$38.8M +44.9% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $122M +$37.4M +44.4% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 $114M +$35.6M +45.6% Dec 31, 2012 10-K 2016-02-19
Q3 2012 $94.9M +$22.7M +31.4% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 $86.5M +$20.3M +30.7% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 $84.2M +$24.6M +41.3% Mar 31, 2012 10-Q 2012-05-09
Q4 2011 $78M +$22.9M +41.6% Dec 31, 2011 10-K 2015-02-20
Q3 2011 $72.2M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 $66.2M Jun 30, 2011 10-Q 2011-08-08
Q1 2011 $59.6M Mar 31, 2011 10-Q 2011-05-09
Q4 2010 $55.1M Dec 31, 2010 10-K 2014-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.